JPWO2020009950A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020009950A5 JPWO2020009950A5 JP2021522925A JP2021522925A JPWO2020009950A5 JP WO2020009950 A5 JPWO2020009950 A5 JP WO2020009950A5 JP 2021522925 A JP2021522925 A JP 2021522925A JP 2021522925 A JP2021522925 A JP 2021522925A JP WO2020009950 A5 JPWO2020009950 A5 JP WO2020009950A5
- Authority
- JP
- Japan
- Prior art keywords
- glucosamine
- cbd
- composition
- pharmaceutically acceptable
- osteoarthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 20
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 20
- 229960002442 glucosamine Drugs 0.000 claims 20
- 238000000034 method Methods 0.000 claims 20
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 19
- 229950011318 cannabidiol Drugs 0.000 claims 19
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 19
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 19
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 229960002849 glucosamine sulfate Drugs 0.000 claims 7
- 201000008482 osteoarthritis Diseases 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 claims 3
- 241000196324 Embryophyta Species 0.000 claims 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims 3
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- 229960001911 glucosamine hydrochloride Drugs 0.000 claims 3
- 229950006780 n-acetylglucosamine Drugs 0.000 claims 3
- 240000007551 Boswellia serrata Species 0.000 claims 2
- 235000012035 Boswellia serrata Nutrition 0.000 claims 2
- 229920002567 Chondroitin Polymers 0.000 claims 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 230000002195 synergetic effect Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000002301 glucosamine derivatives Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862692865P | 2018-07-02 | 2018-07-02 | |
| US62/692,865 | 2018-07-02 | ||
| PCT/US2019/040043 WO2020009950A1 (en) | 2018-07-02 | 2019-07-01 | Cannabidiol combination compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532171A JP2021532171A (ja) | 2021-11-25 |
| JP2021532171A5 JP2021532171A5 (https=) | 2022-06-20 |
| JPWO2020009950A5 true JPWO2020009950A5 (https=) | 2022-06-20 |
Family
ID=69060564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522925A Pending JP2021532171A (ja) | 2018-07-02 | 2019-07-01 | カンナビジオールの組み合わせ組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210275556A1 (https=) |
| EP (1) | EP3817750A4 (https=) |
| JP (1) | JP2021532171A (https=) |
| CN (1) | CN112930183A (https=) |
| AU (1) | AU2019299213A1 (https=) |
| BR (1) | BR112020027097A2 (https=) |
| CA (1) | CA3105082A1 (https=) |
| WO (1) | WO2020009950A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020017023A2 (pt) | 2018-02-23 | 2021-03-02 | Nicola Michael Spirtos | terapêutica à base de cannabis e método de uso |
| IT201900016709A1 (it) * | 2019-09-19 | 2021-03-19 | Aqma Italia S P A | Composizione antidolorifica e antinfiammatoria ad uso locale |
| US20210212950A1 (en) * | 2020-01-15 | 2021-07-15 | Resurgent Pharmaceuticals, Inc. | Orally deliverable formulation to prevent all cause mortality and cardiovascular events |
| US11364255B2 (en) * | 2020-07-01 | 2022-06-21 | Karallief, Inc. | Therapeutic herbal compositions for improving joint health |
| BR102020023664A2 (pt) * | 2020-07-02 | 2022-01-11 | Yuzu Llc | Composições compreendendo canabidiol e flavononas |
| EP4182026A4 (en) * | 2020-07-17 | 2024-10-02 | India Globalization Capital, Inc. | COMPOSITION BASED ON CANNABIDIOL (CBD) AND METHOD FOR TREATING PAIN |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887497B2 (en) * | 2002-12-19 | 2005-05-03 | Vitacost.Com, Inc. | Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function |
| GB2414933B (en) * | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| AU2006249771A1 (en) * | 2005-05-24 | 2006-11-30 | Wellgen, Inc. | Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| JP5204578B2 (ja) * | 2007-07-31 | 2013-06-05 | 全薬工業株式会社 | 関節痛改善用組成物、関節痛改善剤、あるいは食品 |
| PL2444081T3 (pl) * | 2010-10-19 | 2015-09-30 | Parenteral A S | Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol |
| SG10201402819WA (en) * | 2014-06-02 | 2016-01-28 | Beauty Nation Pte Ltd | Composition for prevention and treatment of joint pain and the method of preparation thereof |
| US9486476B2 (en) * | 2014-08-05 | 2016-11-08 | Natures Products, Inc | Fast acting joint relief formulations |
| US10398776B1 (en) * | 2014-11-03 | 2019-09-03 | Essential Green Goodness LLC | Phonophoretic cannabidiol composition and transdermal delivery system |
| AU2016215094B2 (en) * | 2015-02-05 | 2019-09-26 | Colorado Can Llc | Purified CBD and CBDA, and methods, compositions and products employing CBD or CBDA |
| US10542770B2 (en) * | 2016-03-18 | 2020-01-28 | Aceso Wellness LLC | Cannabinoid emulsion product and process for making the same |
| CA3025208A1 (en) * | 2016-05-24 | 2017-11-30 | Bol Pharma Ltd. | Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases |
| US10945967B2 (en) * | 2017-05-30 | 2021-03-16 | Jae Wang. Song | Formulations of a transdermal patch for pain management |
| US20190000794A1 (en) * | 2017-12-27 | 2019-01-03 | Daniel S. Tanaka | Transmucosal cannabinoid formulation including a chitosan excipeint |
| CN112969452A (zh) * | 2018-04-09 | 2021-06-15 | 艾乐文特科学公司 | 用于治疗动物疼痛的大麻提取物 |
| CN110575432B (zh) * | 2018-06-08 | 2021-10-12 | 汉义生物科技（北京）有限公司 | 一种含有大麻二酚的组合物及其在动物用品中的应用 |
| WO2020021545A1 (en) * | 2018-07-25 | 2020-01-30 | Bol Pharma Ltd. | Cannabidiol and glucosamine for treating inflammatory joint diseases |
-
2019
- 2019-07-01 AU AU2019299213A patent/AU2019299213A1/en not_active Abandoned
- 2019-07-01 JP JP2021522925A patent/JP2021532171A/ja active Pending
- 2019-07-01 CN CN201980057334.3A patent/CN112930183A/zh active Pending
- 2019-07-01 WO PCT/US2019/040043 patent/WO2020009950A1/en not_active Ceased
- 2019-07-01 BR BR112020027097-0A patent/BR112020027097A2/pt not_active IP Right Cessation
- 2019-07-01 EP EP19830597.1A patent/EP3817750A4/en not_active Withdrawn
- 2019-07-01 CA CA3105082A patent/CA3105082A1/en active Pending
- 2019-07-01 US US17/257,244 patent/US20210275556A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532171A5 (https=) | ||
| FI4061344T3 (fi) | 6-hydroksikannabidioli käytettäväksi lääkkeenä | |
| Singh et al. | Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens | |
| Kaushik et al. | Therapeutic potentials of cow derived products-a review | |
| CL2023000296A1 (es) | Uso de dexpramipexol para el tratamiento del asma moderado a grave | |
| JPWO2021099781A5 (https=) | ||
| JPWO2021099777A5 (https=) | ||
| JPWO2021099775A5 (https=) | ||
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| JP2016505050A5 (https=) | ||
| JPWO2020009950A5 (https=) | ||
| CN102920771B (zh) | 一种用于治疗家禽球虫病的药物 | |
| CN103622988A (zh) | 虫草素在制备抗抑郁症的药物中的用途及其制备而得的快速抗抑郁症药物 | |
| CN101468025A (zh) | 一种用于防治禽大肠杆菌病的可溶性粉 | |
| DE202007008818U1 (de) | Zusammensetzung zur Behandlung von Infekten | |
| WO2015018471A1 (de) | Lobbyist-zellschutz pni (psychoneuroimmunium) | |
| JP2015091772A (ja) | 抗微生物作用を備えた組成物の製造のためのパチョリ抽出物の使用 | |
| CN102228466A (zh) | 硫酸软骨素氨糖片 | |
| JP6434650B2 (ja) | 糖尿病創傷治療用イソキノリン誘導体の新規使用 | |
| CN105796543B (zh) | U0126在制备治疗帕金森药物上的应用 | |
| CN112843146A (zh) | 中成药三黄膏的新用途 | |
| CN103830378B (zh) | 一种治疗鸡盲肠球虫病中兽药超微粉及其制备方法 | |
| CN108245665A (zh) | 药物组合物及其制备方法和应用 | |
| RU2006114078A (ru) | Лекарственный препарат и способ лечения ревматических заболеваний | |
| CN106109579A (zh) | 一种含甘草、肉桂和阿莫西林的畜禽用复方药物 |